4-(((7-Oxo-7H-thiazolo[5,4-e]indol-8-yl)methyl)amino)-N-(pyridin-2-yl)benzenesulfonamide

Catalog No. :
ACRWEE592
CAS No. :
760211-93-6
Molecular Formula :
C21H15N5O3S2
Molecular Weight :
449.52

IUPAC Name:4-(((7-oxo-7H-thiazolo[5,4-e]indol-8-yl)methyl)amino)-N-(pyridin-2-yl)benzenesulfonamide

4-(((7-Oxo-7H-thiazolo[5,4-e]indol-8-yl)methyl)amino)-N-(pyridin-2-yl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(((7-Oxo-7H-thiazolo[5,4-e]indol-8-yl)methyl)amino)-N-(pyridin-2-yl)benzenesulfonamide
IUPAC Name4-(((7-oxo-7H-thiazolo[5,4-e]indol-8-yl)methyl)amino)-N-(pyridin-2-yl)benzenesulfonamide
Molecular FormulaC21H15N5O3S2
Molecular Weight449.52
SMILESO=C1N=C2C=CC3=C(SC=N3)C2=C1CNC1=CC=C(S(=O)(=O)NC2=CC=CC=N2)C=C1
InChI KeyMBXKBJLIESPLIK-UHFFFAOYSA-N
SynonymBenzenesulfonamide, 4-[[(7-oxo-7H-pyrrolo[2,3-g]benzothiazol-8-yl)methyl]amino]-N-2-pyridinyl-
CAS No.760211-93-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACRWEE592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKWTD320 route compound structure diagram
    ACKWTD32032654-45-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRWEE592 route product structure diagram
    ACRWEE592760211-93-6
Inquiry

2. ACRWEE592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHQSP238 route compound structure diagram
    ACHQSP238144-83-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRWEE592 route product structure diagram
    ACRWEE592760211-93-6
Inquiry

Comments (0)